ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1125

Association between Hyperuricemia and Metabolic Syndrome with or without Obesity: Results from the 2016 Korea National Health and Nutrition Examination Survey

In Young Kim1, Yeong Hee Eun1, Eun-Jung Park2, Joong Kyong Ahn3, Chan Hong Jeon4, Jaejoon Lee5, Hoon-Suk Cha1, Eun-Mi Koh5, Kyungdo Han6 and Hyungjin Kim1, 1Department of Medicine, Division of Rheumatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South), 2Department of Medicine, Division of Rheumatology, National Medical Center, Seoul, Korea, Republic of (South), 3Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South), 4Department of Medicine, Division of Rheumatology, Soonchunhyang University College of Medicine, Bucheon, Korea, Republic of (South), 5Department of Medicine,Division of Rheumatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South), 6Department of Biostatistics, Catholic University of Korea, Seoul, Korea, Republic of (South)

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: hyperuricemia, metabolic syndrome and obesity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Hyperuricemia is increasing worldwide, and is emerging as a potential biomarker and predictor for metabolic syndrome and related complications. We aimed this study to investigate the association between hyperuricemia and metabolic syndrome with or without obesity.

Methods: We performed multivariate logistic regression analyses using the 2016 Korea National Health and Nutrition Examination Survey (KNHANES) data collected in a representative sample of Korean adults (defined by age ≥ 20 years). Hyperuricemia was defined by serum uric acid level ≥7.0 mg/dl for men and ≥6.0 mg/dl for women. Obesity was based on body mass index (BMI) ≥ 25 kg/m2.

Results: Among a total of 5,591 Korean adult participants, 685 (12.3%) individuals were classified as having hyperuricemia. Hyperuricemia was significantly associated with metabolic syndrome in both men (Odd ratio (OR) = 1.74, 95% CI: 1.29-2.34) and women (OR = 2.47, 95% CI: 1.55-3.93) after adjustments for age, sex, smoking, alcohol, exercise, BMI and estimated glomerular filtration rate (eGFR). Obesity was also independently related to hyperuricemia in both sex (OR = 1.70, 95% CI: 1.31-2.19 in men, OR = 3.73, 95% CI: 2.57-5.41 in women). Among the components of metabolic syndrome, elevated blood pressure, elevated triglyceride and reduced high-density lipoprotein (HLD)-cholesterol in men, and increased waist circumference, hyperglycemia, elevated triglyceride in women were risk factors for hyperuricemia. In subgroup analyses, individuals who had metabolic syndrome with obesity were at the highest risk of hyperuricemia, followed by those with metabolic syndrome without obesity in overall population (OR = 3.91, 95% CI: 3.00-5.09, OR = 3.21, 95% CI: 2.28-4.52, respectively). In population with metabolic syndrome, the presence of obesity posed higher risk for hyperuricemia in women compared with men (OR = 7.24, 95% CI: 4.56-11.50 versus OR = 2.90, 95% CI: 2.12-3.96).

Conclusion: Our results indicate that hyperuricemia is independently associated with metabolic syndrome and obesity in both sex. The effect of obesity in increasing the risk of hyperuricemia was more pronounced in women compared to men.


Disclosure: I. Y. Kim, None; Y. H. Eun, None; E. J. Park, None; J. K. Ahn, None; C. H. Jeon, None; J. Lee, None; H. S. Cha, None; E. M. Koh, None; K. Han, None; H. Kim, None.

To cite this abstract in AMA style:

Kim IY, Eun YH, Park EJ, Ahn JK, Jeon CH, Lee J, Cha HS, Koh EM, Han K, Kim H. Association between Hyperuricemia and Metabolic Syndrome with or without Obesity: Results from the 2016 Korea National Health and Nutrition Examination Survey [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/association-between-hyperuricemia-and-metabolic-syndrome-with-or-without-obesity-results-from-the-2016-korea-national-health-and-nutrition-examination-survey/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-hyperuricemia-and-metabolic-syndrome-with-or-without-obesity-results-from-the-2016-korea-national-health-and-nutrition-examination-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology